SCHEMBL8469129

SCHEMBL8469129

N#CC1CCCN1C(=O)C1CNCCN1

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 20/20 0.74
OPRM1 P35372 1/20 0.56
OPRD1 P41143 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5866953 0.91 DPP4 (0.62) DPP4
SCHEMBL1723021 0.85 DPP4 (1.00) DPP4OPRM1OPRD1
SCHEMBL1723023 0.85 DPP4 (1.00) DPP4OPRM1OPRD1
SCHEMBL1723024 0.85 DPP4 (1.00) DPP4OPRM1OPRD1
Hydrochloric Acid SCHEMBL2708883 0.84 DPP4 (0.97) DPP4OPRM1OPRD1
SCHEMBL6167910 0.77 DPP4 (0.85) DPP4OPRM1OPRD1
SCHEMBL6166301 0.77 DPP4 (0.69) DPP4OPRM1OPRD1
SCHEMBL8296996 0.77 DPP4 (0.73) DPP4
SCHEMBL24322709 0.76 DPP4 (1.00) DPP4
Hydrochloric Acid SCHEMBL2710294 0.76 DPP4 (0.71) DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030225102-A1 Novel compounds and therapeutic uses thereof TORRENT PHARMACEUTICALS LTD. 2003-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225102-A1 Novel compounds and therapeutic uses thereof GPR119, SLC5A1, SLC2A4 DPP4 192/4885OPRM1 489/4885OPRD1 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.